Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parent - Business News: Latest News & Videos about market and economy | Trendmergers

Breaking

Post Top Ad

Post Top Ad

Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parent

The money will predominantly be used to refinance the debt the company had taken to fund its acquisition of diagnostics chain Thyrocare last year.

from Industry-Economic Times
Read The Rest:economictimes...

Post Top Ad